155 related articles for article (PubMed ID: 27959454)
1. Clinical significance of Wip1 overexpression and its association with the p38MAPK/p53/p16 pathway in NSCLC.
Yang S; Dong S; Qu X; Zhong X; Zhang Q
Mol Med Rep; 2017 Feb; 15(2):719-723. PubMed ID: 27959454
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of the wip1 gene abrogates the p38 MAPK/p53/Wip1 pathway and silences p16 expression in human breast cancers.
Yu E; Ahn YS; Jang SJ; Kim MJ; Yoon HS; Gong G; Choi J
Breast Cancer Res Treat; 2007 Mar; 101(3):269-78. PubMed ID: 16897432
[TBL] [Abstract][Full Text] [Related]
3. The Regulation of Trophoblastic p53 Homeostasis by the p38-Wip1 Feedback Loop is Disturbed in Placentas from Pregnancies Complicated by Preeclampsia.
Tan B; Tong C; Yuan Y; Xu P; Wen L; Zhang C; Zheng Y; Lin L; Zhu F; Gui S; Wang L; Gao R; Li J; Qi H; Baker PN
Cell Physiol Biochem; 2019; 52(2):315-335. PubMed ID: 30816677
[TBL] [Abstract][Full Text] [Related]
4. Wip1 phosphatase: between p53 and MAPK kinases pathways.
Goloudina AR; Kochetkova EY; Pospelova TV; Demidov ON
Oncotarget; 2016 May; 7(21):31563-71. PubMed ID: 26883196
[TBL] [Abstract][Full Text] [Related]
5. Wip1 regulates SKOV3 cell apoptosis through the p38 MAPK signaling pathway.
Feng Y; Liu F; Du Z; Zhao D; Cheng J; Guo W
Mol Med Rep; 2017 Jun; 15(6):3651-3657. PubMed ID: 28440479
[TBL] [Abstract][Full Text] [Related]
6. WIP1 promotes cancer stem cell properties by inhibiting p38 MAPK in NSCLC.
Deng K; Liu L; Tan X; Zhang Z; Li J; Ou Y; Wang X; Yang S; Xiang R; Sun P
Signal Transduct Target Ther; 2020 Apr; 5(1):36. PubMed ID: 32296033
[TBL] [Abstract][Full Text] [Related]
7. Clinical Significance of the Wild Type p53-Induced Phosphatase 1 Expression in Invasive Breast Cancer.
Inoue Y; Yamashita N; Kitao H; Tanaka K; Saeki H; Oki E; Oda Y; Tokunaga E; Maehara Y
Clin Breast Cancer; 2018 Aug; 18(4):e643-e650. PubMed ID: 29275106
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16(Ink4a)-p19(Arf) pathway.
Bulavin DV; Phillips C; Nannenga B; Timofeev O; Donehower LA; Anderson CW; Appella E; Fornace AJ
Nat Genet; 2004 Apr; 36(4):343-50. PubMed ID: 14991053
[TBL] [Abstract][Full Text] [Related]
9. [The role of Smad4 and MAPK proteins in signal transduction pathway in non-small cell lung cancer].
Tong XD; Liu HX; Zhao HR; Xu SG; Li Y; Han LB; Zhang L
Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):741-5. PubMed ID: 17366784
[TBL] [Abstract][Full Text] [Related]
10. Prognostic implications of cell cycle-related proteins in primary resectable pathologic N2 nonsmall cell lung cancer.
Mohamed S; Yasufuku K; Hiroshima K; Nakajima T; Yoshida S; Suzuki M; Sekine Y; Shibuya K; Iizasa T; Farouk A; Fujisawa T
Cancer; 2007 Jun; 109(12):2506-14. PubMed ID: 17487846
[TBL] [Abstract][Full Text] [Related]
11. The estrogen receptor alpha pathway induces oncogenic Wip1 phosphatase gene expression.
Han HS; Yu E; Song JY; Park JY; Jang SJ; Choi J
Mol Cancer Res; 2009 May; 7(5):713-23. PubMed ID: 19435816
[TBL] [Abstract][Full Text] [Related]
12. PP2Cdelta (Ppm1d, WIP1), an endogenous inhibitor of p38 MAPK, is regulated along with Trp53 and Cdkn2a following p38 MAPK inhibition during mouse preimplantation development.
Hickson JA; Fong B; Watson PH; Watson AJ
Mol Reprod Dev; 2007 Jul; 74(7):821-34. PubMed ID: 17219434
[TBL] [Abstract][Full Text] [Related]
13. Regulation of ATM/p53-dependent suppression of myc-induced lymphomas by Wip1 phosphatase.
Shreeram S; Hee WK; Demidov ON; Kek C; Yamaguchi H; Fornace AJ; Anderson CW; Appella E; Bulavin DV
J Exp Med; 2006 Dec; 203(13):2793-9. PubMed ID: 17158963
[TBL] [Abstract][Full Text] [Related]
14. Expression of Wip1 in kidney carcinoma and its correlation with tumor metastasis and clinical significance.
Sun GG; Wang YD; Liu Q; Hu WN
Pathol Oncol Res; 2015 Jan; 21(1):219-24. PubMed ID: 24970693
[TBL] [Abstract][Full Text] [Related]
15. p53-Independent expression of wild-type p53-induced phosphatase 1 (Wip1) in methylmethane sulfonate-treated cancer cell lines and human tumors.
Park JY; Song JY; Kim HM; Han HS; Seol HS; Jang SJ; Choi J
Int J Biochem Cell Biol; 2012 Jun; 44(6):896-904. PubMed ID: 22405851
[TBL] [Abstract][Full Text] [Related]
16. NF-κB-induced WIP1 expression promotes colorectal cancer cell proliferation through mTOR signaling.
Bai F; Zhou H; Fu Z; Xie J; Hu Y; Nie S
Biomed Pharmacother; 2018 Mar; 99():402-410. PubMed ID: 29367109
[TBL] [Abstract][Full Text] [Related]
17. A novel assay for screening WIP1 phosphatase substrates in nuclear extracts.
Storchova R; Burdova K; Palek M; Medema RH; Macurek L
FEBS J; 2021 Oct; 288(20):6035-6051. PubMed ID: 33982878
[TBL] [Abstract][Full Text] [Related]
18. p38 MAPK signaling pathway activation by phenyl benzoxime in SNU-306 cells causes induction of apoptosis.
Chen W; Tan Y; Zhang Y
Microb Pathog; 2019 Jan; 126():74-78. PubMed ID: 30347260
[TBL] [Abstract][Full Text] [Related]
19. Proto-oncogene Wip1, a member of a new family of proliferative genes in NSCLC and its clinical significance.
Fu Z; Sun G; Gu T
Tumour Biol; 2014 Apr; 35(4):2975-81. PubMed ID: 24272082
[TBL] [Abstract][Full Text] [Related]
20. Expression of a homeostatic regulator, Wip1 (wild-type p53-induced phosphatase), is temporally induced by c-Jun and p53 in response to UV irradiation.
Song JY; Han HS; Sabapathy K; Lee BM; Yu E; Choi J
J Biol Chem; 2010 Mar; 285(12):9067-76. PubMed ID: 20093361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
